NonExomics, Inc.

ACTON, MA · Founded 2021 · CIK 0001855959 · Biotech · Private

Computational platform to identify druggable noncanonical proteins from the human genome

nonexomics.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$200K
1 Form D · Apr 2021
66 months since last filing
Contracts
—
No federal contracts on record
Patents
2
0 granted · 2 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$200,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2630VERRA THERAPEUTICS LLC—$205K
2631ELDEC PHARMACEUTICALS INC.—$200K
2632Reven Holdings Inc—$200K
2633NonExomics, Inc.—$200K
2634FruitVaccine Incorporation——
2635Amalgent Therapeutics, LLC—$200K
2636Rapport Therapeutics——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 1 related persons
  • Ruchi ChauhanDirector

Patents

USPTO · 0 granted of 2
  • Compositions And Methods For Treatment Of Cancerapplication
  • Compositions And Methods For Treatment Of Cancerapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.